|
|
||||||||
MYCOLOGY |





*Laboratoire de Mycologie Fondamentale et Appliquée et Equipe Inserm 9915,
Laboratoire de Parasitologie-Mycologie, CHRU, Faculté de Médecine, Pôle Recherche, F-59045 Lille,
Bio-Rad, Route de Cassel, 59114 Steenvoorde,
Laboratoire de Parasitologie-Mycologie, Hôpital Saint Antoine, 75012 Paris, ||Laboratoire de Parasitologie-Mycologie and **Département d'Hématologie Clinique, Centre Hospitalier Régional Universitaire, Hôpital Le Bocage, Dijon, France
Corresponding author: Dr D. Poulain (e-mail: dpoulain{at}univ-lille2.fr).
Received 1 June 2001; revised version accepted 17 Nov. 2001.
Abstract
A novel strategy for the diagnosis of systemic candidosis was evaluated, based on the combination of two enzyme immunoassays that detect a candida oligomannoside repetitive epitope expressed in large amounts by Candida albicans (Platelia Candida Ag), and antibodies against C. albicans mannan, the major cell-wall immunogen in which this epitope is present (Platelia Candida Ab). Sera were selected retrospectively from intensive care and haematology patients with clinically suspected systemic candidosis, and from whom Candida spp. had been isolated from normally sterile sites. Of the 21 patients infected with C. albicans, 13 had positive antigenaemia and 14 had a positive antibody response, including eight patients who were antigenaemia negative. The sensitivity of the combined tests was 100%. In patients infected with C. glabrata (n=12) or C. tropicalis (n=10), the sensitivity was 83% and 80%, respectively. For the remaining patients, infected with C. parapsilosis (n=10), C. krusei (n=8) or C. kefyr (n=2), the sensitivity of the combined tests was 40%, 50% and 50%, respectively. At least one of the serological tests was positive before yeast growth occurred in 60% of patients for whom a serum sample was available before blood culture sampling. An increase in serological test positivity to >80% was observed for sera obtained around the date of positive culture, irrespective of the Candida species isolated. These results suggest that regular serological monitoring for both mannanaemia and anti-mannan antibodies in at-risk patients may contribute to the early diagnosis of candidosis.
This article has been cited by other articles:
![]() |
M. Ellis, B. Al-Ramadi, R. Bernsen, J. Kristensen, H. Alizadeh, and U. Hedstrom Prospective evaluation of mannan and anti-mannan antibodies for diagnosis of invasive Candida infections in patients with neutropenic fever J. Med. Microbiol., May 1, 2009; 58(5): 606 - 615. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Y. Hachem, D. P. Kontoyiannis, R. F. Chemaly, Y. Jiang, R. Reitzel, and I. Raad Utility of Galactomannan Enzyme Immunoassay and (1,3) {beta}-D-Glucan in Diagnosis of Invasive Fungal Infections: Low Sensitivity for Aspergillus fumigatus Infection in Hematologic Malignancy Patients J. Clin. Microbiol., January 1, 2009; 47(1): 129 - 133. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. Sendid, N. Dotan, S. Nseir, C. Savaux, P. Vandewalle, A. Standaert, F. Zerimech, B. P. Guery, A. Dukler, J. F. Colombel, et al. Antibodies against Glucan, Chitin, and Saccharomyces cerevisiae Mannan as New Biomarkers of Candida albicans Infection That Complement Tests Based on C. albicans Mannan Clin. Vaccine Immunol., December 1, 2008; 15(12): 1868 - 1877. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. J. Clancy, M.-L. Nguyen, S. Cheng, H. Huang, G. Fan, R. A. Jaber, J. R. Wingard, C. Cline, and M. H. Nguyen Immunoglobulin G Responses to a Panel of Candida albicans Antigens as Accurate and Early Markers for the Presence of Systemic Candidiasis J. Clin. Microbiol., May 1, 2008; 46(5): 1647 - 1654. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. Persat, S. Ranque, F. Derouin, A. Michel-Nguyen, S. Picot, and A. Sulahian Contribution of the (1->3)-{beta}-D-Glucan Assay for Diagnosis of Invasive Fungal Infections J. Clin. Microbiol., March 1, 2008; 46(3): 1009 - 1013. [Abstract] [Full Text] [PDF] |
||||
![]() |
S.-i. Fujita, T. Takamura, M. Nagahara, and T. Hashimoto Evaluation of a newly developed down-flow immunoassay for detection of serum mannan antigens in patients with candidaemia. J. Med. Microbiol., May 1, 2006; 55(Pt 5): 537 - 543. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Charlier, E. Hart, A. Lefort, P. Ribaud, F. Dromer, D. W. Denning, and O. Lortholary Fluconazole for the management of invasive candidiasis: where do we stand after 15 years? J. Antimicrob. Chemother., March 1, 2006; 57(3): 384 - 410. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. R. Singleton, J. Masuoka, and K. C. Hazen Surface Hydrophobicity Changes of Two Candida albicans Serotype B mnn4{Delta} Mutants Eukaryot. Cell, April 1, 2005; 4(4): 639 - 648. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Masuoka Surface Glycans of Candida albicans and Other Pathogenic Fungi: Physiological Roles, Clinical Uses, and Experimental Challenges Clin. Microbiol. Rev., April 1, 2004; 17(2): 281 - 310. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Girmenia, P. Martino, F. De Bernardis, M. Boccanera, and A. Cassone Lack of circulating Candida mannoprotein antigen in patients with focal hepatosplenic candidiasis J. Med. Microbiol., February 1, 2004; 53(2): 103 - 106. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. Sendid, D. Caillot, B. Baccouch-Humbert, L. Klingspor, M. Grandjean, A. Bonnin, and D. Poulain Contribution of the Platelia Candida-Specific Antibody and Antigen Tests to Early Diagnosis of Systemic Candida tropicalis Infection in Neutropenic Adults J. Clin. Microbiol., October 1, 2003; 41(10): 4551 - 4558. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Rimek, J. Singh, and R. Kappe Cross-Reactivity of the PLATELIA CANDIDA Antigen Detection Enzyme Immunoassay with Fungal Antigen Extracts J. Clin. Microbiol., July 1, 2003; 41(7): 3395 - 3398. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| INT J SYST EVOL MICROBIOL | J MED MICROBIOL | MICROBIOLOGY | J GEN VIROL | ALL SGM JOURNALS |